You are viewing a limited version of this profile. To access i3's full capabilities.
Lavie Bio
Save
Company logo (jpg or png)
Parent company

Short description

Developer of biological crop inputs using AI-powered discovery

Founded in 2019
Founded in

Company type Acquired Public ()
Company type

Industry Group agriculture & food

Sector crop inputs

TRL Range 7-8
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Israel Rehovot, Israel
Address
City
State
Zip
Country

Parent Companies Evogene

Updated by Cleantech Group on 04/21/2025

Traction
  • 1 M&A items
tags
Similar companies
Customers
Save
Date Company
Partnerships
Save
Date Partner Type
03/20/2024
Syngenta Group Syngenta Group
The collaboration will leverage Lavie Bio’s unique technology platform to rapidly identify and optimize bio-insecticide candidates, as well as Syngenta’s extensive global research, development and commercialization capabilities.
View source    
Confirmed by Syngenta Group
Development Partner
Investment Rounds
Save

IPO INFORMATION

Date

IPO status

IPO Type

Amount

Initial shares

Ticker symbol

Exchange listed

Prospectus URL

Prospectus

Source URL

Source

Description

Date Investors Type Amount
08/07/2019 Corteva Corteva (1)
Post-money valuation of
The transaction includes the exchange of all shares of Corteva’s subsidiary Taxon Biosciences along with an equity investment by Corteva in Lavie. Corteva will be issued approximately 30 percent of Lavie’s equity while Evogene will hold approximately 70 percent of Lavie’s equity.
Seed
Click to add IPO information
Products
Save
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font